Sotera Health (NASDAQ:SHC) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Sotera Health (NASDAQ:SHC - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $15.80.

Several equities analysts recently weighed in on SHC shares. Wall Street Zen downgraded shares of Sotera Health from a "buy" rating to a "hold" rating in a report on Saturday. The Goldman Sachs Group raised shares of Sotera Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $14.00 to $17.00 in a research report on Monday, May 5th. Barclays dropped their price objective on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. Finally, Piper Sandler dropped their price target on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd.

Sotera Health Price Performance

Shares of Sotera Health stock traded down $0.06 on Friday, hitting $12.30. 1,729,389 shares of the company traded hands, compared to its average volume of 1,219,150. The business has a 50-day simple moving average of $11.79 and a 200 day simple moving average of $12.54. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.08. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock has a market capitalization of $3.49 billion, a P/E ratio of 49.20 and a beta of 1.87.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm had revenue of $254.52 million during the quarter, compared to analyst estimates of $245.56 million. During the same period in the previous year, the firm earned $0.13 earnings per share. The business's revenue was up 2.6% on a year-over-year basis. Research analysts expect that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SHC. Blue Trust Inc. raised its position in Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock worth $25,000 after acquiring an additional 1,140 shares in the last quarter. Quarry LP acquired a new stake in shares of Sotera Health in the 4th quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd boosted its position in Sotera Health by 3,690.1% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company's stock worth $31,000 after buying an additional 2,620 shares during the period. Summit Securities Group LLC bought a new position in shares of Sotera Health during the first quarter valued at $67,000. Finally, Farther Finance Advisors LLC lifted its position in shares of Sotera Health by 4,881.9% in the 1st quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock worth $70,000 after purchasing an additional 6,200 shares during the period. Institutional investors own 91.03% of the company's stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.